Rachel Brem

Rachel Brem began their career in 2000 as the Director of the Breast Imaging and Interventional Center and Professor and Vice Chair at GW Medical Faculty Associates. In 2002, they became the Director of Dilon Technologies Inc. and in 2003, they were appointed Director of iCAD. In 2016, Rachel Brem joined The George Washington University Cancer Center as Program Leader for Breast Cancer, and in 2019 they accepted the position of Director at Delphinus Medical Technologies, Inc. In 2021, Rachel Brem began their current role as Director at ScreenPoint Medical.

Rachel Brem holds a Doctor of Medicine (MD) from Columbia University.